Internet survey on the Penetration of Constipation Guidelines Among Psychiatrists - CLIP survey

Internet survey on the Penetration of Constipation Guidelines Among Psychiatrists - CLIP survey - Internet survey on the Penetration of Constipation Guidelines Among Psychiatrists - CLIP survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059499

Enrollment

200

Registered

2025-10-27

Start date

2025-11-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation, schizophrenia, depression

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Psychiatrists registered in the Cross Marketing Co., Ltd. research cooperation panel who have agreed to participate in this survey

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Awareness and level of understanding of clinical guidelines for constipation guidelines	—

Secondary

Measure	Time frame
Age, gender, affiliated medical institution, membership in psychiatric specialty societies, number of patients treated and number of patients with constipation, medications used for constipation, Consideration for renal function when using magnesium oxide, consideration for concomitant medications requiring caution, status of serum magnesium level measurement, number of patients using stimulant laxatives continuously, awareness and usage status of three new mechanism-based constipation treatments, differentiation of laxative use according to constipation pathology, preferred laxative dosage form, preferred laxative administration method, aspects prioritized and their importance when prescribing laxatives, concerns regarding laxatives and their severity	—

Measure

Time frame

Age, gender, affiliated medical institution, membership in psychiatric specialty societies, number of patients treated and number of patients with constipation, medications used for constipation, Consideration for renal function when using magnesium oxide, consideration for concomitant medications requiring caution, status of serum magnesium level measurement, number of patients using stimulant laxatives continuously, awareness and usage status of three new mechanism-based constipation treatments, differentiation of laxative use according to constipation pathology, preferred laxative dosage form, preferred laxative administration method, aspects prioritized and their importance when prescribing laxatives, concerns regarding laxatives and their severity

—

Countries

Japan

Contacts

Public ContactTadashi Shin

EA Pharma Co., Ltd. Medical Science Group, Medical Dept.

tadashi_shin@epharma.co.jp090-8084-1296

Outcome results